Unknown

Dataset Information

0

Microplate-based assay for identifying small molecules that bind a specific intersubunit interface within the assembled HIV-1 capsid.


ABSTRACT: Despite the availability of >30 effective drugs for managing HIV-1 infection, no current therapy is curative, and long-term management is challenging owing to the emergence and spread of drug-resistant mutants. Identification of drugs against novel HIV-1 targets would expand the current treatment options and help to control resistance. The highly conserved HIV-1 capsid protein represents an attractive target because of its multiple roles in replication of the virus. However, the low antiviral potencies of the reported HIV-1 capsid-targeting inhibitors render them unattractive for therapeutic development. To facilitate the identification of more-potent HIV-1 capsid inhibitors, we developed a scintillation proximity assay to screen for small molecules that target a biologically active and specific intersubunit interface in the HIV-1 capsid. The assay, which is based on competitive displacement of a known capsid-binding small-molecule inhibitor, exhibited a signal-to-noise ratio of >9 and a Z factor of >0.8. In a pilot screen of a chemical library containing 2,400 druglike compounds, we obtained a hit rate of 1.8%. This assay has properties that are suitable for screening large compound libraries to identify novel HIV-1 capsid ligands with antiviral activity.

SUBMITTER: Halambage UD 

PROVIDER: S-EPMC4538492 | biostudies-literature | 2015 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Microplate-based assay for identifying small molecules that bind a specific intersubunit interface within the assembled HIV-1 capsid.

Halambage Upul D UD   Wong Jason P JP   Melancon Bruce J BJ   Lindsley Craig W CW   Aiken Christopher C  

Antimicrobial agents and chemotherapy 20150615 9


Despite the availability of >30 effective drugs for managing HIV-1 infection, no current therapy is curative, and long-term management is challenging owing to the emergence and spread of drug-resistant mutants. Identification of drugs against novel HIV-1 targets would expand the current treatment options and help to control resistance. The highly conserved HIV-1 capsid protein represents an attractive target because of its multiple roles in replication of the virus. However, the low antiviral po  ...[more]

Similar Datasets

| S-EPMC3623829 | biostudies-literature
| S-EPMC4839650 | biostudies-literature
| S-EPMC5697708 | biostudies-literature
| S-EPMC6576259 | biostudies-literature
| S-EPMC3854666 | biostudies-literature
| S-EPMC6350814 | biostudies-literature
| S-EPMC6600197 | biostudies-literature
| S-EPMC2752052 | biostudies-literature
| EMPIAR-11570 | biostudies-other
| S-EPMC109620 | biostudies-literature